期刊文献+

褪黑素纳米粒的制备工艺研究 被引量:1

Preparation of Biodegradable Nanoparticles Loaded with Melatonin
下载PDF
导出
摘要 目的:制备褪黑素载药纳米粒并对其影响因素进行研究。方法:以聚乳酸、壳聚糖可生物降解材料为载体,明胶为分散剂,Span -80和Tween- 80混合液为乳化剂,采用复乳 溶剂挥发法制备载药纳米粒,根据纳米粒的表面形态、粒径大小、分布、包封率、载药量选择最佳工艺条件,制备褪黑素纳米粒。结果:原子力显微镜观察纳米粒表面圆滑,分布均匀。正交设计效应曲线图直观分析和方差分析结果,均显示搅拌速度、溶剂挥发温度、聚乳酸与褪黑素投料比、壳聚糖浓度是影响制备工艺的主要因素。结论:在30℃;10 0 0r/min搅拌速度;褪黑素与聚乳酸的质量比为1∶3;Tween 80与Span 80体积比为5∶1;壳聚糖质量分数为1%情况下,可制备成平均粒径在4 5 . 84nm ,包封率为38.33% ,载药量为8 .35 %的褪黑素载药纳米粒。 AIM:To prepare nanoparticles loaded with melato nin by co-emulsification-solvent evaporation technique. METHOD: Ba sed on the poly-lactic acid and chitosan as biodegradable carrier,gelatin was us ed as dispersion,microemulsion was preparated by mixture of Span-80 and Tween -80 .According to shapes,sizes of particles,dispersion,content of drug loadi ng, entrapment efficiency and character of nanoparticles,chance best technique to prepare nanoparticles loaded with melatonin.RESULT: AFM(ato m ic force microscope probe) shows that glaze of nanoparticles and uniformity of d ispersion.That effective curve and analysis of variance showed that reaction t e mperature,stirring speed,ratio of Poly-lactic acid and melatonin,concent rati on of chitosan were the main factors.CONCLUSION:MT-NPs were pr eparated in the optimum factors of reaction temperation 30 ℃,stirring speed 1 000 r/min,ratio of PLA and MT 3∶1,ratio of Tween-80 and Span-80 5∶1,conc entration of chitosan 1% and the average particle sizes was 45.84 nm,the d rug loading were 8.35%,entrapment efficiency were 38.33%.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2005年第2期129-133,共5页 Journal of China Pharmaceutical University
关键词 褪黑素 聚乳酸 壳聚糖 纳米粒 制备 Melatonin PLA Chitosan Nanoparticles Preparat ion
  • 相关文献

参考文献12

  • 1杨凯,温玉明,李龙江,王昌美,王涛,李文.舌鳞状细胞癌预后因素的探讨[J].华西口腔医学杂志,2001,19(3):161-163. 被引量:10
  • 2付爱玲,李经才,杨红英.褪黑素的体内过程[J].医药导报,1999,18(3):191-192. 被引量:10
  • 3徐连敏.壳聚糖纳米粒的研究进展[J].国外医学(药学分册),2002,29(6):329-332. 被引量:29
  • 4Karbownik M, Reiter R J, Cabrerea J, et al. Comparison of the protective effect of melatonin with other antioxidants in the hamster kidney model of estradiol-induced DNA damage [ J ]. Mutation Research, 2001,474: 87 - 92.
  • 5Grippa E, Pavone F, Teria M, et oJ. In vitro evaluation of antioxidant activity by electrophoresis and high performance liquid chromatography[J]. Biochimica et Biophysica Acta , 2000 , 1524:171- 177.
  • 6Russel J, Reiter, Dun XT. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart[J]. Cardiovascular Research,2003,58:10 - 19.
  • 7赵瑞玲,丁红,谢茵.阿霉素聚乳酸微球制备工艺研究[J].山西医科大学学报,2001,32(5):420-421. 被引量:8
  • 8Kobayashi O, OnoderaS, RinoY, et al. Evaluation of medicinal lymph node dissection in advanced gastric cancer[J], Nippon Gnka Gakkai Zasshi, 1994,95(12) :860 - 865.
  • 9Douglas SJ, Davis SS, Illum L. Nanopartides in drug delivery[J]. Crit Rev Ther Drug Carrier Syst , 1987,3(3) :233 - 261.
  • 10Song CX, Labhasetwar V, Murphy H, et al. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery[J]. J Control Rel, 1997, 43(3) : 197 - 212.

二级参考文献37

  • 1常津.具有复合靶向抗癌功能的纳米高分子材料[J].中国生物医学工程学报,1996,15(2):97-101. 被引量:44
  • 2常津.纳米高分子材料在抗癌药物控释方面的应用[J].中国生物医学工程学报,1996,15(2):102-106. 被引量:10
  • 3盛洁,魏树礼.阿霉素毫微球制剂的研究进展[J].国外医药(合成药.生化药.制剂分册),1996,17(1):34-37. 被引量:3
  • 4陶忠华.聚乳酸类生物降解聚合物在控释制剂中的应用[J].药学进展,1996,20(4):197-203. 被引量:8
  • 5顾学裘.褪黑素与癌[J].医药导报,1998,17(2):67-69.
  • 6Schwarz C, Mehnert W. Solid liquid nanoparticles (SLN) for controlled drug delivery Ⅱ . Drug incorporation and physicochemical characterization[J]. J Microencapsulation, 1999,16(2) :205-213.
  • 7Song CX, Labhasetwar V, Murohy H, et al. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery[ J ]. J Control Rel, 1997,43 : 197-212.
  • 8Hincal A. Atilla, Kas, H. Suheyla. Recent advances in nanoparticles and nanospheres[C]. Biomed Sci. Technol. [ Proc. Int.Syrmp, 4th, Meeting Date], 1997,31-39.
  • 9Erbacher P, Zou S, Bettingger T, et al. Chitosan based vector/DNA complexed for gene delivery: biophysical characteristics and transfection ability[J]. Pharm Res, 1998,15(9):1332-1339.
  • 10Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency[J]. J Control Release, 2001, 70(3):399 - 421.

共引文献80

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部